scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AHJ.2005.08.015 |
P698 | PubMed publication ID | 16781214 |
P50 | author | John A. Spertus | Q59976170 |
William E Boden | Q60503412 | ||
Koon Teo | Q60611748 | ||
Daniel S Berman | Q89697826 | ||
Leslee J Shaw | Q94570815 | ||
William S Weintraub | Q98158272 | ||
Bernard R Chaitman | Q114407034 | ||
William J Kostuk | Q114407037 | ||
Merril Knudtson | Q114407046 | ||
Paul Casperson | Q114407048 | ||
P2093 | author name string | G B John Mancini | |
David J Maron | |||
Marcin Dada | |||
Pamela M Hartigan | |||
Crystal L Harris | |||
Robert A O'rourke | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | veteran | Q193891 |
revascularization | Q7317735 | ||
P304 | page(s) | 1173-9 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424 | |
P478 | volume | 151 |
Q35927515 | A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina |
Q34364029 | Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke). |
Q92216896 | Acute and Long-Term Outcomes of Patients with Impaired Left Ventricular Systolic Function Undergoing Rotational Atherectomy: A Single-Center Observational Retrospective Study |
Q92305786 | Deafening Silence: The Lack of Structured Patient Symptoms in Clinical Documentation of Angina |
Q30319078 | Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? |
Q42632315 | Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial). |
Q60921612 | Endothelial Function: A Short Guide for the Interventional Cardiologist |
Q37521237 | Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial |
Q45332629 | Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424. |
Q59355879 | How and When to Decide on Revascularization in Stable Ischemic Heart Disease |
Q57339258 | Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society |
Q91519288 | Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes |
Q42602556 | Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug E |
Q83181418 | Medical and Catheter-Based Therapies for Managing Stable Coronary Disease: Lessons From the COURAGE Trial |
Q38004987 | Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. |
Q39249132 | Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience |
Q37140881 | Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options |
Q38845089 | Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease |
Q38552516 | Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease. |
Q26796452 | Role of short-acting nitroglycerin in the management of ischemic heart disease |
Q38212580 | Stable angina pectoris. |
Q33696402 | The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...] |
Q41748514 | Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial). |
Search more.